Injection site pain with long-acting risperidone
Pinninti, N.R.; Mago, R.
Journal of Clinical Psychiatry 66(5): 656-7; Author Reply 657
2005
ISSN/ISBN: 0160-6689 PMID: 15889958 Document Number: 594132
Because this piece has no we have provided for your benefit the first 3 sentences of the full text.' ‹Sir: In a recent report in the Journal,1 only 1 of 141 patientsin a 12-week multicenter trial of injectable long-acting risperidonecomplained of pain at the site of injection, which was mild. Pain at the injection site has been noted to be a problem withfirst-generation antipsychotics.
Document emailed within 1 workday
Related Documents
Arunpongpaisal, S.; Srisurapanont, M.; Kongsakon, R.; Kitiwattanagul, K.; Samanwongthai, U. 2010: Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia Journal of the Medical Association of Thailand 93(3): 343-350Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Llorca, P-M.; Sacchetti, E.; Lloyd, K.; Kissling, W.; Medori, R. 2008: Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 months International Journal of Clinical Pharmacology and Therapeutics 46(1): 14-22
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Davey, L.A.; Ferber, M.T.; Kaye, B. 1985: Comparison of the serum pharmacokinetics of a long acting and a conventional oxytetracycline injection Veterinary Record 117(17): 426-429
Carbonell, A.M.; Harold, K.L.; Mahmutovic, A.J.; Hassan, R.; Matthews, B.D.; Kercher, K.W.; Sing, R.F.; Heniford, B.T. 2003: Local injection for the treatment of suture site pain after laparoscopic ventral hernia repair American Surgeon 69(8): 688-691; Discussion: 691-692
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Belsey, E.M. 1991: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation Advances in contraception: the official journal of the Society for the Advancement of Contraception 7(2-3): 257-270
Suzuki, Y. 2016: The Safety of Using Long-acting Injections : from an Opposing Position-Is it Better to Administer Long-acting Injections? Seishin Shinkeigaku Zasshi 118(8): 584-588
Dávila-Parrilla, A.; Santaella-Santé, B.; Otero-López, A. 2015: Does Injection Site Matter? a Randomized Controlled Trial to Evaluate Different Entry Site Efficacy of Knee Intra-articular Injections Boletin de la Asociacion Medica de Puerto Rico 107(2): 78-81
McCusker, J.; Stoddard, A.M.; Koblin, B.A.; Sullivan, J.; Lewis, B.F.; Sereti, S.M. 1992: Time trends in high-risk injection practices in a multi-site study in Massachusetts: effects of enrollment site and residence Aids Education and Prevention: Official Publication of the International Society for Aids Education 4(2): 108-119
Krobbuaban, B.; Siriwan, D.; Kumkeaw, S.; Tanomsat, M.; Jamjamrat, G.; Thanetses, K.; Kosittanasan, S. 2008: Does addition of lidocaine to medium- and long-chain triglyceride propofol emulsions significantly reduce pain on injection? Journal of the Medical Association of Thailand 91(3): 383-387
Outman, W.R.; Monolakis, J. 1991: Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection American Journal of Hospital Pharmacy 48(7): 1539-1541
Yokono, K. 2001: Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2127-2133
Borison, R.L. 1996: Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing Clinical Therapeutics 18(4): 592-607; discussion 591
Das, M.; Anand, A.; Hossain, B.; Ansari, S. 2022: Inequalities in short-acting reversible, long-acting reversible and permanent contraception use among currently married women in India Bmc Public Health 22(1): 1264
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Ulusoy, G.ök.R.; Bilge, A.; Öztürk, Öm.ür. 2019: Comparison of corticosteroid injection and ozone injection for relief of pain in chronic lateral epicondylitis Acta Orthopaedica Belgica 85(3): 317-324
Veys, N.; Dhondt, A.; Lameire, N. 1998: Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta Clinical Nephrology 49(1): 41-44
Mendoza, R.M.; Garbers, S.; Lin, S.; Stockwell, M.S.; Warren, M.; Gold, M.A. 2020: Chlamydia Infection Among Adolescent Long-Acting Reversible Contraceptive and Shorter-Acting Hormonal Contraceptive Users Receiving Services at new York City School-Based Health Centers Journal of Pediatric and Adolescent Gynecology 33(1): 53-57